In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ademetionine Disulfate Tosylate Drug Master File in Korea (Ademetionine Disulfate Tosylate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ademetionine Disulfate Tosylate. The MFDS reviews the Ademetionine Disulfate Tosylate KDMF as part of the drug registration process and uses the information provided in the Ademetionine Disulfate Tosylate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ademetionine Disulfate Tosylate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ademetionine Disulfate Tosylate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ademetionine Disulfate Tosylate suppliers with KDMF on PharmaCompass.